Chapnick B M
Am J Physiol. 1984 Apr;246(4 Pt 2):H518-24. doi: 10.1152/ajpheart.1984.246.4.H518.
Influences of leukotrienes C4 (LTC4), D4 (LTD4), and E4 (LTE4) on mesenteric and renal blood flow were investigated in the anesthetized dog. Blood flow was measured with noncannulating electromagnetic flow probes, and all agonists were injected as a bolus close arterially. When injected into the superior mesenteric artery, LTC4 (0.1-3.0 ng), LTD4 (0.1-1.0 ng), and LTE4 (1-30 ng) produced dose-dependent decreases in blood flow in absence of a change in mean arterial pressure. When compared with intestinal vasoconstrictor responses caused by angiotension II, which was most active, and norepinephrine, which was least active, the leukotrienes were intermediate between these two well-known vasoactive hormones. LTD4 was more active than LTC4, and both were considerably more active than LTE4. In contrast to the intestine, injection of leukotrienes (1,000 ng) into the kidney resulted in little to no change in renal blood flow or mean arterial pressure, but mesenteric flow decreased 10-15 s later. Administration of indomethacin (5 mg/kg iv) did not alter mesenteric vasoconstrictor responses produced by LTD4. However, mesenteric vasoconstrictor responses to prostaglandin (PG)D2 were reduced after indomethacin, whereas renal vasodilation caused by PGD2 was unaffected. These results demonstrate that LTC4, LTD4, and LTE4 differentially affect blood flow in the intestine and kidney and suggest that if circulating levels of leukotrienes are increased, blood flow would be expected to be diverted away from the intestine. These data are thus compatible with the hypothesis that leukotrienes may participate in regulation of peripheral regional blood flow.(ABSTRACT TRUNCATED AT 250 WORDS)
在麻醉犬身上研究了白三烯C4(LTC4)、D4(LTD4)和E4(LTE4)对肠系膜和肾血流的影响。使用非插管式电磁血流探头测量血流,所有激动剂均通过动脉推注给药。当注入肠系膜上动脉时,LTC4(0.1 - 3.0纳克)、LTD4(0.1 - 1.0纳克)和LTE4(1 - 30纳克)在平均动脉压无变化的情况下,使血流呈剂量依赖性减少。与活性最强的血管紧张素II和活性最弱的去甲肾上腺素引起的肠道血管收缩反应相比,白三烯的活性介于这两种著名的血管活性激素之间。LTD4比LTC4更具活性,两者均比LTE4活性高得多。与肠道不同,向肾脏注射白三烯(1000纳克)后,肾血流或平均动脉压几乎没有变化,但肠系膜血流在10 - 15秒后减少。静脉注射吲哚美辛(5毫克/千克)并未改变LTD4引起的肠系膜血管收缩反应。然而,吲哚美辛后肠系膜对前列腺素(PG)D2的血管收缩反应减弱,而PGD2引起的肾血管舒张不受影响。这些结果表明,LTC4、LTD4和LTE4对肠道和肾脏的血流有不同影响,并提示如果循环中的白三烯水平升高,预计血流会从肠道分流。因此这些数据与白三烯可能参与外周区域血流调节的假说相符。(摘要截短至250字)